All lobbying filings

SL STRATEGIES, LLC

SL STRATEGIES, LLC filed a Q3 report for BAVARIAN NORDIC on October 20, 2026, reporting $40,000 in lobbying income.

Lobbying for BAVARIAN NORDIC · Pharmaceutical company

All filings by SL STRATEGIES, LLC · Everything BAVARIAN NORDIC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund

Health Issues

Pandemic All Hazards Preparedness Act (PAHPA) reauthorization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.